Intracellular delivery system for antibody-peptide drug conjugates

Geoffrey Y. Berguig, Anthony J. Convertine, Shani Frayo, Hanna B. Kern, Erik Procko, Debashish Roy, Selvi Srinivasan, Daciana H. Margineantu, Garrett Booth, Maria Corinna Palanca-Wessels, David Baker, David Hockenbery, Oliver W. Press, Patrick S. Stayton

Research output: Contribution to journalArticlepeer-review


Antibodies armed with biologic drugs could greatly expand the therapeutic potential of antibody-drug conjugates for cancer therapy, broadening their application to disease targets currently limited by intracellular delivery barriers. Additional selectivity and new therapeutic approaches could be realized with intracellular protein drugs that more specifically target dysregulated pathways in hematologic cancers and other malignancies. A multifunctional polymeric delivery system for enhanced cytosolic delivery of protein drugs has been developed that incorporates endosomal-releasing activity, antibody targeting, and a biocompatible long-chain ethylene glycol component for optimized safety, pharmacokinetics, and tumor biodistribution. The pH-responsive polymeric micelle carrier, with an internalizing anti-CD22 monoclonal targeting antibody, effectively delivered a proapoptotic Bcl-2 interacting mediator (BIM) peptide drug that suppressed tumor growth for the duration of treatment and prolonged survival in a xenograft mouse model of human B-cell lymphoma. Antitumor drug activity was correlated with a mechanistic induction of the Bcl-2 pathway biomarker cleaved caspase-3 and a marked decrease in the Ki-67 proliferation biomarker. Broadening the intracellular target space by more effective delivery of protein/peptide drugs could expand the repertoire of antibody-drug conjugates to currently undruggable disease-specific targets and permit tailored drug strategies to stratified subpopulations and personalized medicines.

Original languageEnglish (US)
Pages (from-to)907-917
Number of pages11
JournalMolecular Therapy
Issue number5
StatePublished - May 9 2015

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Intracellular delivery system for antibody-peptide drug conjugates'. Together they form a unique fingerprint.

Cite this